NCT00201357View on ClinicalTrials.gov

An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Hormone-refractory Prostate Cancer
Interventions
DRUG

Thalidomide (THADO)

patients who receive thalidomide (100 mg BID).

Trial Locations (1)

104

Mackay Memorial Hospital, Taipei

All Listed Sponsors
lead

National Health Research Institutes, Taiwan

OTHER

NCT00201357 - An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer | Biotech Hunter | Biotech Hunter